Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
The DOI matches its Crossref record; 158 of the 169 references it cites were found in a registry or an index.
Abstract
Objective: To update the "Testosterone Therapy in Men With Androgen Deficiency Syndromes" guideline published in 2010. Participants: The participants include an Endocrine Society-appointed task force of 10 medical content experts and a clinical practice guideline methodologist. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation approach to describe the strength of recommendations and the quality of evidence. The task force commissioned two systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications facilitated consensus development. Endocrine Society committees and members and the cosponsoring organization were invited to review and comment on preliminary drafts of the guideline. Conclusions: We recommend making a diagnosis of hypogonadism only in men with symptoms and signs consistent with testosterone (T) deficiency and unequivocally and consistently low serum T concentrations. We recommend measuring fasting morning total T concentrations using an accurate and reliable assay as the initial diagnostic test. We recommend confirming the diagnosis by repeating the measurement of morning fasting total T concentrations. In men whose total T is near the lower limit of normal or who have a condition that alters sex hormone-binding globulin, we recommend obtaining a free T concentration using either equilibrium dialysis or estimating it using an accurate formula. In men determined to have androgen deficiency, we recommend additional diagnostic evaluation to ascertain the cause of androgen deficiency. We recommend T therapy for men with symptomatic T deficiency to induce and maintain secondary sex characteristics and correct symptoms of hypogonadism after discussing the potential benefits and risks of therapy and of monitoring therapy and involving the patient in decision making. We recommend against starting T therapy in patients who are planning fertility in the near term or have any of the following conditions: breast or prostate cancer, a palpable prostate nodule or induration, prostate-specific antigen level > 4 ng/mL, prostate-specific antigen > 3 ng/mL in men at increased risk of prostate cancer (e.g., African Americans and men with a first-degree relative with diagnosed prostate cancer) without further urological evaluation, elevated hematocrit, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, myocardial infarction or stroke within the last 6 months, or thrombophilia. We suggest that when clinicians institute T therapy, they aim at achieving T concentrations in the mid-normal range during treatment with any of the approved formulations, taking into consideration patient preference, pharmacokinetics, formulation-specific adverse effects, treatment burden, and cost. Clinicians should monitor men receiving T therapy using a standardized plan that includes: evaluating symptoms, adverse effects, and compliance; measuring serum T and hematocrit concentrations; and evaluating prostate cancer risk during the first year after initiating T therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TRT is also contra-indicated in people with (high risk of) prostate cancer, a history of breast cancer, thrombophilia, elevated hematocrit, untreated severe obstructive sleep apnea, uncontrolled heart failure, and myocardial infarction or stroke within the last 6 months [3].”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [3]
In the citing paper
“It suppresses spermatogenesis, and thus, cannot be used in patients with a desire to have children in the near future.”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [3]
In the citing paper
“It may result in gynecomastia, acne, testicular atrophy and erythrocytosis.”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [3]
In the citing paper
“The Endocrine Society guideline emphasizes the importance of lifestyle changes in men with central hypogonadism and comorbidities [3].”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [3]
In the citing paper
“Hyperprolactinemia also suppresses the secretion of GnRH and the response of gonadotropins to GnRH secretion.”
From Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy (2020) · cites this paper as [3]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031918 · Cited by 2,446
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Self-citationSex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Self-citationAdverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Self-citationHeidenreich, A., Bastian, P. J., Bellmunt, J., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.11.002 · Cited by 1,341
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176 · cited 1×
“culated from TT, SHBG, and albumin levels (23, 24).”
Harrison's Principles of Internal Medicine
Massarelli, J. J. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03340300091039 · Cited by 1,132
The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
Gormley, G. J., Stoner, E., Bruskewitz, R. C., Imperato-McGinley, J., Walsh, P. C., McConnell, J. D., Andriole, G. L., Geller, J., Bracken, B. R., Tenover, J. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210223271701 · Cited by 1,124
Vigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Self-citationWu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1972 · Cited by 939
Self-citationEffects of Testosterone Treatment in Older Men
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506119 · Cited by 890
Self-citationBoehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L., Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A., et al. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.112 · Cited by 874 · cited 1×
“…or extreme obesity ( e.g. , Prader – Willi syndrome), polydactyly, syndactyly, synkinesia, anosmia, kidney abnormalities ( e.g. , Kallmann syndrome), or short stature ( e.g. , contiguous gene deletions of chromosome X) — can help clinicians identify specific syndromes via pattern recognition (48).”
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Hormones, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm323 · Cited by 786
Loss of Circadian Rhythmicity in Blood Testosterone Levels with Aging in Normal Men*
Bremner, W. J., Vitiello, M. V., & Prinz, P. N. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1278 · Cited by 785
Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
Calof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Self-citationPrevalence of Symptomatic Androgen Deficiency in Men
Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1245 · Cited by 720 · cited 1×
“In surveys of community-dwellingmiddle-aged and older men, low libido, erectile dysfunction, and less specific symptoms (such as fatigue, irritability, depressed mood, poor concentration, reduced physical performance, and sleep disturbance) are associated with low T concentrations (10, 11).”
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2575 · Cited by 713
Self-citationEndogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Araujo, A. B., Dixon, J. M., Suarez, E. A., Murad, M. H., Guey, L. T., & Wittert, G. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1137 · Cited by 671
Validation of a screening questionnaire for androgen deficiency in aging males
Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M. (2000) · Metabolism · doi:10.1053/meta.2000.8625 · Cited by 662
Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1058 · Cited by 658
Self-citationFrequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631 · cited 9×
“A meta-analysis of RCTs of men with T2DM and/or the metabolic syndrome found no evidence of an improvement in HbA1c (141).”
InfluentialSrinivas-Shankar, U., Roberts, S. A., Connolly, M. J., O'Connell, M. D. L., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1251 · Cited by 629
Self-citationOsteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3045 · Cited by 611
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592
Self-citationEffects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 572
Self-citationDHEA in elderly women and DHEA or testosterone in elderly men.
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054629 · Cited by 566
Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1933 · Cited by 566
Self-citationBhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1184 · Cited by 544 · cited 1×
“The effects of T on muscle/fat mass and muscle strength are related to the administered dose and increase in circulating T concentrations (75 – 77).”
Self-citationEffect of Testosterone Treatment on Body Composition and Muscle Strength in Men Over 65 Years of Age
Snyder, P. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2647 · Cited by 531
Self-citationTestosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men1
Bhasin, S., Storer, T. W., Berman, N., Yarasheski, K. E., Clevenger, B., Phillips, J., Lee, W. P., Bunnell, T. J., & Casaburi, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3733 · Cited by 522
Self-citationEmmelot-Vonk, M. H., Verhaar, H. J. J., Nakhai Pour, H. R., Aleman, A., Lock, T. M. T. W., Bosch, J. L. H. R., Grobbee, D. E., & van der Schouw, Y. T. (2008) · JAMA · doi:10.1001/jama.2007.51 · Cited by 518
Effects of Testosterone Replacement in Hypogonadal Men
Snyder, P. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2670 · Cited by 464
Self-citationTestosterone replacement therapy improves mood in hypogonadal men--a clinical research center study
Wang, C. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3578 · Cited by 453
Self-citationBrambilla, D. J., Matsumoto, A. M., Araujo, A. B., & McKinlay, J. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1902 · Cited by 448 · cited 3×
“Despite this attenuation of the diurnal rhythm in older men, a substantial fraction of 65-to 80-year-old men who have low serum T concentrations in the afternoon will have normal T concentrations in the morning (9).”
Self-citationBrodsky, I. G., Balagopal, P., & Nair, K. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855787 · Cited by 444 · cited 1×
“T therapy in healthy men with hypogonadism increases fat-free mass (73, 74) and muscle strength (73, 75).”
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0447 · Cited by 435
A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications
Goldman, A. L., Bhasin, S., Wu, F. C. W., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00025 · Cited by 414
Self-citationSteidle, C., Schwartz, S., Jacoby, K., Sebree, T., Smith, T., & Bachand, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021058 · Cited by 411
Travison, T. G., Araujo, A. B., Kupelian, V., O’Donnell, A. B., & McKinlay, J. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1859 · Cited by 410
Effects of graded doses of testosterone on erythropoiesis in healthy young and older men
Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1692 · Cited by 404
Muraleedharan, V., Marsh, H., Kapoor, D., Channer, K. S., & Jones, T. H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0321 · Cited by 389
Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone
Budoff, M. J., Ellenberg, S. S., Lewis, C. E., Mohler, E. R., Wenger, N. K., Bhasin, S., Barrett-Connor, E., Swerdloff, R. S., Stephens-Shields, A., Cauley, J. A., et al. (2017) · JAMA · doi:10.1001/jama.2016.21043 · Cited by 376
Self-citationType 2 diabetes mellitus and testosterone: a meta-analysis study: Type 2 diabetes and testosterone
Corona, G., Monami, M., Rastrelli, G., Aversa, A., Sforza, A., Lenzi, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01117.x · Cited by 370
Bhasin, S. (2000) · JAMA · doi:10.1001/jama.283.6.763 · Cited by 369
Self-citationSnyder, P. J., Kopperdahl, D. L., Stephens-Shields, A. J., Ellenberg, S. S., Cauley, J. A., Ensrud, K. E., Lewis, C. E., Barrett-Connor, E., Schwartz, A. V., Lee, D. C., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9539 · Cited by 363
Self-citationBhasin, S., Pencina, M., Jasuja, G. K., Travison, T. G., Coviello, A., Orwoll, E., Wang, P. Y., Nielson, C., Wu, F., Tajar, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-3012 · Cited by 355
Self-citationHaddad, R. M., Kennedy, C. C., Caples, S. M., Tracz, M. J., Boloña, E. R., Sideras, K., Uraga, M. V., Erwin, P. J., & Montori, V. M. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.1.29 · Cited by 331
Travison, T. G., Vesper, H. W., Orwoll, E., Wu, F., Kaufman, J. M., Wang, Y., Lapauw, B., Fiers, T., Matsumoto, A. M., & Bhasin, S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2935 · Cited by 326 · cited 3×
“The reported reference ranges for TT and FT concentrations in healthy young men vary considerably among laboratories and assays (31).”
InfluentialSelf-citationTestosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men
Bhasin, S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.407 · Cited by 317
Self-citationCatalona, W. J., Hudson, M. A., Scardino, P. T., Richie, J. P., Ahmann, F. R., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32300-5 · Cited by 316
Hormonal Predictors of Prostate Cancer: A Meta-Analysis
Shaneyfelt, T., Husein, R., Bubley, G., & Mantzoros, C. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.847 · Cited by 310
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · cited 1×
“A detailed description of the grading scheme has been published elsewhere (2).”
Sharma, R., Oni, O. A., Gupta, K., Chen, G., Sharma, M., Dawn, B., Sharma, R., Parashara, D., Savin, V. J., Ambrose, J. A., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv346 · Cited by 302
High Serum Testosterone Is Associated With Reduced Risk of Cardiovascular Events in Elderly Men
Ohlsson, C., Barrett-Connor, E., Bhasin, S., Orwoll, E., Labrie, F., Karlsson, M. K., Ljunggren, Ö., Vandenput, L., Mellström, D., & Tivesten, Å. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.019 · Cited by 292
Self-citationDhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Sandhu, S., Green, K., Makdissi, A., Hejna, J., Chaudhuri, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1518 · Cited by 286
Basaria, S., Harman, S. M., Travison, T. G., Hodis, H., Tsitouras, P., Budoff, M., Pencina, K. M., Vita, J., Dzekov, C., Mazer, N. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.8881 · Cited by 268
Self-citationThe Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone
Fowler, J. E., & Whitmore, W. F. (1981) · Journal of Urology · doi:10.1016/s0022-5347(17)54531-0 · Cited by 261
Haddad, R. M., Kennedy, C. C., Caples, S. M., Tracz, M. J., Boloña, E. R., Sideras, K., Uraga, M. V., Erwin, P. J., & Montori, V. M. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60964-6 · Cited by 251
Platz, E. A., Leitzmann, M. F., Rifai, N., Kantoff, P. W., Chen, Y.-C., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0371 · Cited by 245
Increased Incidence of Diagnosed Depressive Illness in HypogonadalOlder Men
Shores, M. M., Sloan, K. L., Matsumoto, A. M., Moceri, V. M., Felker, B., & Kivlahan, D. R. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.2.162 · Cited by 243
Self-citationStimulation of Spermatogenesis by Gonadotropins in Men with Hypogonadotropic Hypogonadism
Finkel, D. M., Phillips, J. L., & Snyder, P. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509123131102 · Cited by 240
Self-citationAssociation of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial
Roy, C. N., Snyder, P. J., Stephens-Shields, A. J., Artz, A. S., Bhasin, S., Cohen, H. J., Farrar, J. T., Gill, T. M., Zeldow, B., Cella, D., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9540 · Cited by 239 · cited 1×
“1 g/dL compared with those in the placebo arm (131).”
Self-citationAnkerst, D. P., Hoefler, J., Bock, S., Goodman, P. J., Vickers, A., Hernandez, J., Sokoll, L. J., Sanda, M. G., Wei, J. T., Leach, R. J., et al. (2014) · Urology · doi:10.1016/j.urology.2014.02.035 · Cited by 236 · cited 1×
“Clinicians can estimate the prostate cancer risk using the prostate cancer risk calculator (119), which considers doi: 10.”
Testosterone and Aging: Clinical Research Directions
(2004) · National Academies Press eBooks · doi:10.17226/10852 · Cited by 231
Genetic determinants of serum testosterone concentrations in men
Ohlsson, C., Wallaschofski, H., Lunetta, K. L., Stolk, L., Perry, J. R. B., Koster, A., Petersen, A.-K., Eriksson, J., Lehtimäki, T., Huhtaniemi, I. T., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002313 · Cited by 224
Self-citationBhasin, S., Singh, A. B., Mac, R. P., Carter, B., Lee, M. I., & Cunningham, G. R. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02676.x · Cited by 221
Self-citationResnick, S. M., Matsumoto, A. M., Stephens-Shields, A. J., Ellenberg, S. S., Gill, T. M., Shumaker, S. A., Pleasants, D. D., Barrett-Connor, E., Bhasin, S., Cauley, J. A., et al. (2017) · JAMA · doi:10.1001/jama.2016.21044 · Cited by 220
Self-citationRabkin, J. G., Wagner, G. J., & Rabkin, R. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.141 · Cited by 213
Factors affecting spermatogenesis upon gonadotropin-replacement therapy: A meta-analytic study
Rastrelli, G., Corona, G., Mannucci, E., & Maggi, M. (2014) · Andrology · doi:10.1111/andr.262 · Cited by 211 · cited 1×
“Uncontrolled studies show that gonadotropin therapy can reinitiate spermatogenesis in men with hypogonadotropic hypogonadism who have been treated previously with T-replacement therapy (126).”
Brambilla, D. J., O'Donnell, A. B., Matsumoto, A. M., & McKinlay, J. B. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02976.x · Cited by 207
Self-citationSmith, K. W., Feldman, H. A., & McKinlay, J. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01152.x · Cited by 203 · cited 1×
“There is limited information about the performance properties of case-detection questionnaires that rely on self-reports, namely Androgen Deficiency in Aging Males (42), the Aging Males ’ Symptoms Rating Scale (43), and the Massachusetts Male Aging Study Questionnaire (44).”
Guideline panels should not GRADE good practice statements
Guyatt, G. H., Schünemann, H. J., Djulbegovic, B., & Akl, E. A. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.011 · Cited by 201
Gonadal steroid–dependent effects on bone turnover and bone mineral density in men
Finkelstein, J. S., Lee, H., Leder, B. Z., Burnett-Bowie, S.-A. M., Goldstein, D. W., Hahn, C. W., Hirsch, S. C., Linker, A., Perros, N., Servais, A. B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84137 · Cited by 198 · cited 10×
“The cost-effectiveness of measuring BMD and the frequency at which it should be performed are not known.”
InfluentialNeuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone
Spratt, D. I., O'Dea, L. S., Schoenfeld, D., Butler, J., Rao, P. N., & Crowley, W. F. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.5.e658 · Cited by 194 · cited 1×
“Also, a small fraction of healthy young men have a T concentration below the normal range during a 24-hour period (22).”
Tsertsvadze, A., Fink, H. A., Yazdi, F., MacDonald, R., Bella, A. J., Ansari, M. T., Garritty, C., Soares-Weiser, K., Daniel, R., Sampson, M., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-9-200911030-00150 · Cited by 193
Klinefelter syndrome: Expanding the phenotype and identifying new research directions
Simpson, J. L., de la Cruz, F., Swerdloff, R. S., Samango-Sprouse, C., Skakkebaek, N. E., Graham, J. M., Hassold, T., Aylstock, M., Meyer-Bahlburg, H. F. L., Willard, H. F., et al. (2003) · Genetics in Medicine · doi:10.1097/01.gim.0000095626.54201.d0 · Cited by 184
Self-citationTestosterone treatment and risk of venous thromboembolism: population based case-control study
Martinez, C., Suissa, S., Rietbrock, S., Katholing, A., Freedman, B., Cohen, A. T., & Handelsman, D. J. (2016) · BMJ · doi:10.1136/bmj.i5968 · Cited by 181
Predictive accuracy and sources of variability in calculated free testosterone estimates
Sartorius, G., Ly, L. P., Sikaris, K., McLachlan, R., & Handelsman, D. J. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008171 · Cited by 175
Antonio, L., Wu, F. C. W., O'Neill, T. W., Pye, S. R., Ahern, T. B., Laurent, M. R., Huhtaniemi, I. T., Lean, M. E. J., Keevil, B. G., Rastrelli, G., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4106 · Cited by 174
Self-citationRietschel, P., Corcoran, C., Stanley, T., Basgoz, N., Klibanski, A., & Grinspoon, S. (2000) · Clinical Infectious Diseases · doi:10.1086/317457 · Cited by 171
Cheetham, T. C., An, J., Jacobsen, S. J., Niu, F., Sidney, S., Quesenberry, C. P., & VanDenEeden, S. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9546 · Cited by 171
Dose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men
Woodhouse, L. J., Gupta, N., Bhasin, M., Singh, A. B., Ross, R., Phillips, J., & Bhasin, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031492 · Cited by 171
Self-citationGianatti, E. J., Dupuis, P., Hoermann, R., Strauss, B. J., Wentworth, J. M., Zajac, J. D., & Grossmann, M. (2014) · Diabetes Care · doi:10.2337/dc13-2845 · Cited by 168
Spitzer, M., Basaria, S., Travison, T. G., Davda, M. N., Paley, A., Cohen, B., Mazer, N. A., Knapp, P. E., Hanka, S., Lakshman, K. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00004 · Cited by 163
Rasmussen, J. J., Selmer, C., Østergren, P. B., Pedersen, K. B., Schou, M., Gustafsson, F., Faber, J., Juul, A., & Kistorp, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161208 · Cited by 163
Mohr, B. A., Bhasin, S., Link, C. L., O’Donnell, A. B., & McKinlay, J. B. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02241 · Cited by 163 · cited 1×
“The fall in T concentrations with age is gradual, and varies in different individuals with higher rates of decline in men with adiposity and comorbid diseases (12, 128, 129).”
Self-citationTestosterone and aging: Clinical research directions: (720062007-001)
(2003) · PsycEXTRA Dataset · doi:10.1037/e720062007-001 · Cited by 162
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels
Cunningham, G. R., Stephens-Shields, A. J., Rosen, R. C., Wang, C., Bhasin, S., Matsumoto, A. M., Parsons, J. K., Gill, T. M., Molitch, M. E., Farrar, J. T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1645 · Cited by 162
Self-citationEffects of Hypogonadism and Testosterone Administration on Depression Indices in HIV-Infected Men
Grinspoon, S. K., Corcoran, C. P., Stanley, T. L., Baaj, A., Basgoz, N. O., & Klibanski, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6224 · Cited by 161
Kanayama, G., Hudson, J. I., DeLuca, J. R., Isaacs, S. K., Baggish, A. L., Weiner, R. B., Bhasin, S., & Pope, H. G. (2015) · Addiction · doi:10.1111/add.12850 · Cited by 154
Self-citationBhasin, S., Travison, T. G., Storer, T. W., Lakshman, K., Kaushik, M., Mazer, N. A., Ngyuen, A.-H., Davda, M. N., Jara, H., Aakil, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.227 · Cited by 152
Self-citationKenyon, A. T., Knowlton, K., Sandiford, I., Koch, F. C., & Lotwin, G. (1940) · Endocrinology · doi:10.1210/endo-26-1-26 · Cited by 150
Low Testosterone Levels in Elderly Men With Dysthymic Disorder
Seidman, S. N., de Araújo, A. B., Roose, S. P., Devanand, D. P., Xie, S., Cooper, T. B., & McKinlay, J. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.456 · Cited by 150
The Aging Males’ Symptoms Scale (AMS) as Outcome Measure for Treatment of Androgen Deficiency
Moore, C., Huebler, D., Zimmermann, T. P., Heinemann, L. A. J., Saad, F., & Thai, D. M. (2004) · European Urology · doi:10.1016/j.eururo.2004.01.009 · Cited by 149
Ponce, O. J., Spencer-Bonilla, G., Alvarez-Villalobos, N., Serrano, V., Singh-Ospina, N., Rodriguez-Gutierrez, R., Salcido-Montenegro, A., Benkhadra, R., Prokop, L. J., Bhasin, S., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00404 · Cited by 148
Self-citationGrossmann, M., Hoermann, R., Wittert, G., & Yeap, B. B. (2015) · Clinical Endocrinology · doi:10.1111/cen.12664 · Cited by 139 · cited 1×
“Some studies have demonstrated a favorable effect of T on insulin sensitivity in men with T2DM (142 – 144), whereas others showed no benefit (145, 146).”
Anabolic Steroid Induced Hypogonadism in Young Men
Coward, R. M., Rajanahally, S., Kovac, J. R., Smith, R. P., Pastuszak, A. W., & Lipshultz, L. I. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.06.010 · Cited by 137
Borst, S. E., Shuster, J. J., Zou, B., Ye, F., Jia, H., Wokhlu, A., & Yarrow, J. F. (2014) · BMC Medicine · doi:10.1186/s12916-014-0211-5 · Cited by 135
Anderson, J. L., May, H. T., LAPPE, D. L., Bair, T. L., Le, V. T., Carlquist, J. F., & Muhlestein, J. B. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.11.063 · Cited by 135
Shores, M. M., Kivlahan, D. R., Sadak, T. I., Li, E. J., & Matsumoto, A. M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04478 · Cited by 133
Self-citationLow bone density in patients receiving methadone maintenance treatment
Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.05.027 · Cited by 131
Buvat, J., Montorsi, F., Maggi, M., Porst, H., Kaipia, A., Colson, M. H., Cuzin, B., Moncada, I., Martin-Morales, A., Yassin, A., et al. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01956.x · Cited by 131
Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis
Alexander, G. C., Iyer, G. S., Lucas, E. J., Lin, D. H., & Singh, S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.09.017 · Cited by 127
Caronia, L. M., Dwyer, A. A., Hayden, D., Amati, F., Pitteloud, N., & Hayes, F. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04486.x · Cited by 125
Self-citationBasaria, S., Travison, T. G., Alford, D., Knapp, P. E., Teeter, K., Cahalan, C., Eder, R., Lakshman, K., Bachman, E., Mensing, G., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460308.86819.aa · Cited by 125
Self-citationProstate Cancer Screening — A Perspective on the Current State of the Evidence
Pinsky, P. F., Prorok, P. C., & Kramer, B. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmsb1616281 · Cited by 124
Testosterone suppression in opioid users: A systematic review and meta-analysis
Bawor, M., Bami, H., Dennis, B. B., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Steiner, M., Anglin, R., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.038 · Cited by 123 · cited 1×
“…measuring T concentrations; these include men with low libido, erectile dysfunction, infertility, HIV-associated weight loss, osteoporosis or low-trauma fracture, a history of AAS use, and men receiving opioids or other drugs or substances that affect T production or metabolism (5, 6, 35 – 41).”
Brock, G., Heiselman, D., Maggi, M., Kim, S. W., Rodríguez Vallejo, J. M., Behre, H. M., McGettigan, J., Dowsett, S. A., Hayes, R. P., Knorr, J., et al. (2016) · Journal of Urology · doi:10.1016/j.juro.2015.10.083 · Cited by 109
Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy
Baillargeon, J., Urban, R. J., Morgentaler, A., Glueck, C. J., Baillargeon, G., Sharma, G., & Kuo, Y.-F. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.05.012 · Cited by 107
Debruyne, F. M. J., Behre, H. M., Roehrborn, C. G., Maggi, M., Wu, F. C. W., Schröder, F. H., Jones, T. H., Porst, H., Hackett, G. I., Wheaton, O. A., et al. (2016) · British Journal of Urology · doi:10.1111/bju.13578 · Cited by 97
Self-citationEffects of Hypogonadism and Testosterone Administration on Depression Indices in HIV-Infected Men
Grinspoon, S. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.60 · Cited by 95
Pope, H. G., Amiaz, R., Brennan, B. P., Orr, G., Weiser, M., Kelly, J. F., Kanayama, G., Siegel, A., Hudson, J. I., & Seidman, S. N. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181d207ca · Cited by 90 · cited 1×
“T therapy does not improve depressive symptoms in men with clinical depression (63).”
Halpern, J. A., Oromendia, C., Shoag, J. E., et al. (2017) · The Journal of Urology · doi:10.1016/j.juro.2017.10.021 · Cited by 90
Analysis of variation in prostate-specific antigen values
Riehmann, M., Rhodes, P. R., Cook, T. D., Grose, G. S., & Bruskewitz, R. C. (1993) · Urology · doi:10.1016/0090-4295(93)90364-g · Cited by 87
Screening and overdiagnosis: public health implications
Bulliard, J., & Chioléro, A. (2015) · Public health reviews · doi:10.1186/s40985-015-0012-1 · Cited by 83
Ory, J., Flannigan, R. K., Lundeen, C. J., Huang, J. G., Pommerville, P. J., & Goldenberg, S. L. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.04.069 · Cited by 82
A multi-step, dynamic allosteric model of testosterone's binding to sex hormone binding globulin
Zakharov, M. N., Bhasin, S., Travison, T. G., Xue, R., Ulloor, J., Vasan, R. S., Carter, E., Wu, F., & Jasuja, R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.001 · Cited by 81
Self-citationPaduch, D. A., Polzer, P. K., Ni, X., & Basaria, S. S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4434 · Cited by 74
Srinath, R., Golden, S. H., Carson, K. A., & Dobs, A. S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3934 · Cited by 73
Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis
Kong, A. H., & Edmonds, P. M. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00441-3 · Cited by 71
Aminorroaya, A., Kelleher, S., Conway, A. J., Ly, L. P., & Handelsman, D. J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01920 · Cited by 71
Huang, G. T.-W., Wharton, W., Bhasin, S., Harman, S. M., Pencina, K. M., Tsitouras, P. D., Li, Z., Hally, K., Asthana, S., Storer, T. W., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30102-4 · Cited by 66
Self-citationSeidman, S. N., Orr, G., Raviv, G., Levi, R., Roose, S. P., Kravitz, E., Amiaz, R., & Weiser, M. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a39137 · Cited by 65
Lehtihet, M., Arver, S., Bartuseviciene, I., & Pousette, Å. (2012) · Andrologia · doi:10.1111/j.1439-0272.2012.01296.x · Cited by 61
Arver, S., Sinha‐Hikim, I., Beall, G. N., GUERRERO, M., Shen, R., & Bhasin, S. (1999) · Journal of Andrology · doi:10.1002/j.1939-4640.1999.tb02562.x · Cited by 57
Self-citationAnawalt, B. D., Hotaling, J. M., Walsh, T. J., & Matsumoto, A. M. (2012) · Journal of Urology · doi:10.1016/j.juro.2011.11.095 · Cited by 55
Self-citationSex Hormone Binding Globulin Deficiency Due to a Homozygous Missense Mutation
Vos, M. J., Mijnhout, G. S., Rondeel, J. M. M., Baron, W., & Groeneveld, P. H. P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2055 · Cited by 47
Kathrins, M. N., Doersch, K., Nimeh, T., Canto, A., Niederberger, C., & Seftel, A. D. (2015) · Urology · doi:10.1016/j.urology.2015.11.006 · Cited by 45
Jasuja, G. K., Bhasin, S., Reisman, J. I., Hanlon, J. T., Miller, D. R., Morreale, A. P., Pogach, L. M., Cunningham, F. E., Park, A., Berlowitz, D. R., et al. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3940-7 · Cited by 44
Self-citationThrombophilia in 67 Patients With Thrombotic Events After Starting Testosterone Therapy
Glueck, C. J., Prince, M., Patel, N., Patel, J., Shah, P. K., Mehta, N., & Wang, P. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615619486 · Cited by 41
Swerdloff, R. S., Pak, Y., Wang, C., Liu, P. Y., Bhasin, S., Gill, T. M., Matsumoto, A. M., Pahor, M., Surampudi, P., & Snyder, P. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1542 · Cited by 39
Self-citationMore on Biotin Treatment Mimicking Graves' Disease.
Kummer, S., Hermsen, D. F., & Distelmaier, F. (2016) · PubMed · doi:10.1056/nejmc1611875 · Cited by 39
Summary statement on screening for prostate cancer in Europe
Heijnsdijk, E. A. M., Bangma, C. H., Borràs, J. M., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31102 · Cited by 37
Khazai, B., Golden, S. H., Colangelo, L. A., Swerdloff, R. S., Wang, C., Honoris, L., Gapstur, S. M., Ouyang, P., Cushman, M., Li, D., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12997 · Cited by 37
Self-citationOpioids increase hip fracture risk: a meta-analysis
Ping, F., Wang, Y., Wang, J., Chen, J., Zhang, W., Zhi, H., & Liu, Y. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-016-0755-x · Cited by 36
Giagulli, V. A., Triggiani, V., Carbone, M. D., Corona, G., Tafaro, E., Licchelli, B., & Guastamacchia, E. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02497.x · Cited by 32
The responsible use of antibiotics for an elevated PSA level
Scardino, P. T. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0702 · Cited by 30
Dalvi, M., Walker, B. R., Strachan, M. W. J., Zammitt, N. N., & Gibb, F. W. (2016) · Clinical Endocrinology · doi:10.1111/cen.13015 · Cited by 29
Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men
Slama, L., Jacobson, L. P., Li, X., Palella, F. J., Margolick, J. B., Kingsley, L., Wiley, D. J., Pialoux, G., Dobs, A. S., & Brown, T. T. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000821 · Cited by 27
Anabolic steroids for the treatment of weight loss in HIV-infected individuals
Johns, K., Beddall, M., & Corrin, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002836.pub2 · Cited by 27
Current trends and problems in health screening
Wilson, J. M. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.26.8.555 · Cited by 27
Matsumoto, A. M., & Bremner, W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00019-8 · Cited by 27
Self-citationHalpern, J. A., Shoag, J. E., Mittal, S., Oromendia, C., Ballman, K. V., Hershman, D. L., Wright, J. D., Shih, Y. T., Nguyen, P. L., & Hu, J. C. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.08.092 · Cited by 27
The effects of opioids on the endocrine system: an overview
Ali, K., Raphael, J. H., Khan, S., Labib, M. H., & Duarte, R. V. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134299 · Cited by 24
Dias, J. P., Shardell, M. D., Carlson, O. D., Melvin, D., Caturegli, G., Ferrucci, L., Chia, C. W., Egan, J. M., & Basaria, S. (2017) · Andrology · doi:10.1111/andr.12284 · Cited by 22
Hayes, R. P., Henne, J., & Kinchen, K. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12542 · Cited by 18
Bhasin, S., Travison, T. G., O’Brien, L. M., MacKrell, J. G., Krishnan, V., Ouyang, H., Pencina, K. M., & Basaria, S. S. (2017) · Andrology · doi:10.1111/andr.12428 · Cited by 15
Self-citationSerum Testosterone Levels During Chronic Glucocorticoid Therapy
Reid, I. R. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-639 · Cited by 14
Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire
Gelhorn, H. L., Dashiell-Aje, E., Miller, M. G., Derogatis, L. R., Dobs, A. S., Seftel, A. D., Althof, S. E., Brod, M. I., & Revicki, D. A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.09.006 · Cited by 13
Jones, T. H., Howell, J. D., & Channer, K. S. (2011) · Diabetes Care · doi:10.2337/dc11-1484 · Cited by 2
Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.00005.114
Self-citation
Research works printed but not linked: 1
- Bhasin, 2015, Disorders of the testes and male reproductive system
Cited by
Cardiovascular Risks Associated with Gender and Aging
Rodgers, J. L., Jones, J., Bolleddu, S. I., Vanthenapalli, S., Rodgers, L. E., Shah, K., Karia, K., & Panguluri, S. K. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6020019 · Cited by 1,024
“While a majority of men show diminished testosterone levels with advanced age, these levels are still considered within the normal physiological range, without symptoms of androgen deficiency and hypogonadism [148].”
BackgroundSalonia, A., Bettocchi, C., Boeri, L., Capogrosso, P., Carvalho, J., Cilesiz, N. C., Cocci, A., Corona, G., Dimitropoulos, K., Gül, M., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.06.007 · Cited by 828
“5 ng/dl) are associated with hypogonadal symptoms (Table 1) [7,26,27].”
BackgroundUsing human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L.-S., Barroso-Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 532
Cardiovascular Safety of Testosterone-Replacement Therapy
Lincoff, A. M., Bhasin, S., Flevaris, P., Mitchell, L. M., Basaria, S., Boden, W. E., Cunningham, G. R., Granger, C. B., Khera, M., Thompson, I. M., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2215025 · Cited by 475
Self-citation
Metadata
- Authors
- Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Baylor College of Medicine (US)
- Massachusetts General Hospital (US)
- University of Southern California (US)
- VA Puget Sound Health Care System (US)
- University of Pennsylvania (US)
- University of California, Los Angeles (US)
- University of Manchester (GB)
- Corresponding author
- Bhasin, Shalender
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-03-17
- Volume
- 103
- Issue
- 5
- Pages
- 1715-1744
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2791298691
- Cited by
- 1,736
- References
- 169
- Citations by year
- 2026: 263 · 2025: 196 · 2024: 198 · 2023: 199 · 2022: 240 · 2021: 221 · 2020: 201 · 2019: 157 · 2018: 56
- FWCI
- 126.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, male hypogonadism, androgen deficiency, sex hormone-binding globulin, secondary sexual characteristics, treatment monitoring, patient decision-making, pharmacokinetics, sleep apnea, thrombophilia, heart failure, lower urinary tract symptoms, fertility preservation
- MeSH terms
- Aged, Aged, 80 and over, Aging, Blood Chemical Analysis, Diagnostic Techniques, Endocrine, Endocrinology, Humans, Hypogonadism, Male, Middle Aged, Societies, Medical, Testosterone, Evidence-Based Medicine, Hormone Replacement Therapy, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.